v1
Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma.
Identifier:nobleid.org/w1/20260515/AF9AE0CF
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/AF9AE0CF)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims